Free access to the McMaster Textbook app and website We are thrilled to announce free access to the McMaster Textbook app and website for users in Canada and the United States. Click to read more.
Indefinite anticoagulation for VTE: reduced-dose vs full-dose DOAC therapy A digest of noteworthy publications handpicked by McMaster experts. This week’s focus: reduced-dose vs full-dose direct anticoagulant (DOAC) therapy for patients requiring indefinite anticoagulations.
New antihypertensive drugs and scheduled surgery How long after the introduction of a new antihypertensive drug should the patient wait for a scheduled surgery? When to reintroduce antihypertensive drugs after surgery? With Dr Maria Lorenza Muiesan.
Corticosteroid regimens in sepsis When do you start corticosteroids in patients with sepsis? Which drug do you choose and how do you decide when to stop? With Dr Bram Rochwerg.
Dasatinib-induced chylothorax in a patient with chronic myeloid leukemia A case report presented by Dr Sergio Agustín Bueno, Argentina. Recorded at Best Case Report Contest 2024.
SGLT2 inhibitors and kidney dysfunctionMcMaster Perspective Extended Dr Gordon Guyatt discusses the changing landscape of diabetes treatment, reviewing the latest high-quality evidence and offering insight into the effectiveness of SGLT2 inhibitors in patients with kidney dysfunction.
McMaster ranked one of world’s top 60 universities for life sciences and medicine McMaster is one of the world’s best universities at which to study life sciences and medicine, ranking 59th internationally, according to the most recent QS World University Rankings by subject.
GLP-1 drugs and weight loss in patients without diabetes A digest of noteworthy publications handpicked by McMaster experts. This week’s focus: GLP-1 receptor agonists for weight loss in patients without diabetes.
A puzzling prelude: Bowel perforation unveiling the diagnosis of atypical familial Mediterranean fever A case report presented by Dr Sarah Al Qassimi, United Arab Emirates. Recorded at Best Case Report Contest 2024.
Bone marrow biopsy in hypereosinophilia of unknown etiology Should we perform bone marrow biopsy in patients with hypereosinophilia of unknown etiology without features of a myeloproliferative neoplasm? With Dr Florence Roufosse.
English
Polski
Español
українська
